research Psychiatric and sexual dysfunction warnings strengthened for finasteride and dutasteride
The MHRA announced on 11 May 2026 that it will update the product information for finasteride and dutasteride to include more details on potential psychiatric and sexual side effects, following a review of existing evidence.
